Erratum: Baicalein Selectively Induces Apoptosis in Activated Lymphocytes and Ameliorates Concanavalin A-Induced Hepatitis in Mice (PLoS ONE (2013) 8:7 (e69592) DOI: 10.1371/journal.pone.0069592);Baicalein Selectively Induces Apoptosis in Activated Lymphocytes and Ameliorates Concanavalin A-Induced Hepatitis in Mice

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Zhang, Yan ^a   Shan, Lei ^a   Hua, Yaping ^b   Wang, Dan ^a   Zeng, Huawu ^a   Liu, Runhui ^a   Zhang, Weidong ^a   Hu, Zhenlin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAICALEIN; CASPASE 3; CASPASE 8; CASPASE 9; CD19 ANTIGEN; CONCANAVALIN A; CYTOCHROME C; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; CD3+ T LYMPHOCYTE; CELL CULTURE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOSOL; DENDRITIC CELL; ENZYME ACTIVATION; FATTY LIVER; FEMALE; HEPATITIS; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; SPLEEN CELL; UPREGULATION; WESTERN BLOTTING;

EID: 84880666556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117635     Document Type: Erratum

References (51)

1. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, et al. (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51: 2193-2213.
2. Gilbert KM, (2010) Xenobiotic exposure and autoimmune hepatitis. Hepat Res Treat 2010: 248157.
3. Heneghan MA, McFarlane IG, (2002) Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35: 7-13.
4. Giovannetti A, Pierdominici M, Di Iorio A, Cianci R, Murdaca G, et al. (2008) Apoptosis in the homeostasis of the immune system and in human immune mediated diseases. Curr Pharm Des 14: 253-268.
5. Hildeman D, Jorgensen T, Kappler J, Marrack P, (2007) Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol 19: 516-521.
6. Yachida M, Kurokohchi K, Arima K, Nishioka M, (1999) Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis. Clin Exp Immunol 116: 140-145.
7. Nagata S, (1997) Apoptosis by death factor. Cell 88: 355-365.
8. Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima H, et al. (2005) Fas polymorphisms influence susceptibility to autoimmune hepatitis. Am J Gastroenterol 100: 1322-1329.
9. Agarwal K, Czaja AJ, Donaldson PT, (2007) A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens 69: 227-235.
10. Tiegs G, Hentschel J, Wendel A, (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 90: 196-203.
11. Chen D, McKallip RJ, Zeytun A, Do Y, Lombard C, et al. (2001) CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J Immunol 166: 5889-5897.
12. Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, et al. (2012) Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 55: 1954-1964.
13. Zhou T, Song L, Yang P, Wang Z, Lui D, et al. (1999) Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Nat Med 5: 42-48.
14. Singh NP, Hegde VL, Hofseth LJ, Nagarkatti M, Nagarkatti P, (2007) Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 72: 1508-1521.
15. Sun Y, Qin Y, Gong FY, Wu XF, Hua ZC, et al. (2009) Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice. Biochem Pharmacol 77: 1717-1724.
16. Di Carlo G, Borrelli F, Ernst E, Izzo AA, (2001) St John's wort: Prozac from the plant kingdom. Trends Pharmacol Sci 22: 292-297.
17. Wang Z, Qiu J, Guo TB, Liu A, Wang Y, et al. (2007) Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis. J Immunol 179: 5958-5965.
18. Sekiya K, Okuda H, (1982) Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Commun 105: 1090-1095.
19. Li C, Lin G, Zuo Z, (2011) Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos 32: 427-445.
20. Shen YC, Chiou WF, Chou YC, Chen CF, (2003) Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol 465: 171-181.
21. Cheng PY, Lee YM, Wu YS, Chang TW, Jin JS, et al. (2007) Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem Pharmacol 73: 793-804.
22. Kubo M, Matsuda H, Tanaka M, Kimura Y, Okuda H, et al. (1984) Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix. Chem Pharm Bull (Tokyo) 32: 2724-2729.
23. Yang LP, Sun HL, Wu LM, Guo XJ, Dou HL, et al. (2009) Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest Ophthalmol Vis Sci 50: 2319-2327.
24. Yun MY, Yang JH, Kim DK, Cheong KJ, Song HH, et al. (2010) Therapeutic effects of Baicalein on atopic dermatitis-like skin lesions of NC/Nga mice induced by dermatophagoides pteronyssinus. Int Immunopharmacol 10: 1142-1148.
25. Dou W, Mukherjee S, Li H, Venkatesh M, Wang H, et al. (2012) Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitis. PLoS One 7: e36075.
26. Ding XZ, Iversen P, Cluck MW, Knezetic JA, Adrian TE, (1999) Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun 261: 218-223.
27. Tong WG, Ding XZ, Adrian TE, (2002) The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Commun 296: 942-948.
28. Pidgeon GP, Kandouz M, Meram A, Honn KV, (2002) Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res 62: 2721-2727.
29. Chen FL, Wang XZ, Li JY, Yu JP, Huang CY, et al. (2008) 12-lipoxygenase induces apoptosis of human gastric cancer AGS cells via the ERK1/2 signal pathway. Dig Dis Sci 53: 181-187.
30. Chow JM, Shen SC, Wu CY, Chen YC, (2006) 12-o-Tetradecanoylphorbol 13-acetate prevents baicalein-induced apoptosis via activation of protein kinase C and JNKs in human leukemia cells. Apoptosis 11: 1999-2011.
31. Liu ZL, Tanaka S, Horigome H, Hirano T, Oka K, (2002) Induction of apoptosis in human lung fibroblasts and peripheral lymphocytes in vitro by Shosaiko-to derived phenolic metabolites. Biol Pharm Bull 25: 37-41.
32. Chen T, Guo J, Yang M, Han C, Zhang M, et al. (2004) Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 103: 413-421.
33. Mansour MK, Latz E, Levitz SM, (2006) Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells. J Immunol 176: 3053-3061.
34. Chandra D, Liu JW, Tang DG, (2002) Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J Biol Chem 277: 50842-50854.
35. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, et al. (2012) Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol 56: 26-33.
36. Savill J, Fadok V, Henson P, Haslett C, (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14: 131-136.
37. Geske FJ, Monks J, Lehman L, Fadok VA, (2002) The role of the macrophage in apoptosis: hunter, gatherer, and regulator. Int J Hematol 76: 16-26.
38. Kroemer G, Reed JC, (2000) Mitochondrial control of cell death. Nat Med 6: 513-519.
39. Peter ME, Krammer PH, (1998) Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10: 545-551.
40. Chen CJ, Raung SL, Liao SL, Chen SY, (2004) Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia. Biochem Pharmacol 67: 957-965.
41. Woo KJ, Lim JH, Suh SI, Kwon YK, Shin SW, et al. (2006) Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology 211: 359-368.
42. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G, (1995) Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198.
43. Kusters S, Gantner F, Kunstle G, Tiegs G, (1996) Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology. 111: 462-471.
44. Gillis S, Crabtree GR, Smith KA, (1979) Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 123: 1624-1631.
45. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, et al. (1996) The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80: S40-45.
46. Abraham RT, Wiederrecht GJ, (1996) Immunopharmacology of rapamycin. Annu Rev Immunol 14: 483-510.
47. Strauss G, Osen W, Debatin KM, (2002) Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol 128: 255-266.
48. Brunetti M, Martelli N, Colasante A, Piantelli M, Musiani P, et al. (1995) Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood 86: 4199-4205.
49. Liu W, Tian R, Hu W, Jia Y, Jiang H, et al. (2012) Preparation and evaluation of self-microemulsifying drug delivery system of baicalein. Fitoterapia 83: 1532-1539.
50. Liu J, Qiu L, Gao J, Jin Y, (2006) Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Int J Pharm 312: 137-143.
51. Zhang J, Lv H, Jiang K, Gao Y, (2011) Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm 420: 180-188.